CBTp vs Motivational Interviewing

A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.

At a glance

Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.

CBTp

Tradition
Cognitive-Behavioral
Founder
Kingdon / Turkington (1994)
Review status
1 condition assessment available
Official sources
Guidelines and official sources (5)

5 clinical guideline checks

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • Psychosis and schizophrenia in adults: prevention and management (CG178)

    NICE · 2014; updated 4 September 2026; psychological recommendations retain 2009/2014 dates · Clinical guideline · 1.4.4.1; 1.3.7.1

    Recommendation for the stated population

    NICE says to offer CBT to all people within this guideline population.

    Scope: Adults with psychosis or schizophrenia, including acute episodes and later care

    Source checked

  • Management of First-Episode Psychosis and Schizophrenia

    VA/DoD · 2023; full PDF labelled Version 2.0, April 2023 · Clinical guideline · Recommendation 32; pp.37,88–89

    Recommendation for the stated population

    VA/DoD suggests CBTp combined with pharmacotherapy (weak for). Preserve the population and combination-treatment scope.

    Scope: Adults with prodromal or early psychosis.

    Source checked

  • Management of First-Episode Psychosis and Schizophrenia

    VA/DoD · 2023; full PDF labelled Version 2.0, April 2023 · Clinical guideline · Recommendation 33; pp.37,89–94

    Recommendation for the stated population

    VA/DoD suggests CBTp combined with pharmacotherapy among several psychotherapy options (weak for). It does not establish superiority over every other option.

    Scope: Adults with schizophrenia.

    Source checked

  • Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

    World Health Organization · Third edition, 20 November 2023 · Clinical guideline · PSY10, pp. 101–102 (PDF pp. 133–134)

    Recommendation for the stated population

    WHO conditionally recommends considering CBT where sufficient specialist support is available, with moderate-certainty evidence. Delivery by non-specialists requires planned specialist supervision.

    Scope: Adults with psychotic disorders, including schizophrenia, in the acute phase.

    Source checked

  • Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

    World Health Organization · Third edition, 20 November 2023 · Clinical guideline · PSY11, pp. 103–105 (PDF pp. 135–137)

    Recommendation for the stated population

    WHO strongly recommends CBT among the listed psychosocial interventions, with moderate-certainty evidence. The option to use those psychosocial interventions alone or together does not establish that medication should be stopped.

    Scope: Adults with psychosis, including schizophrenia, during maintenance treatment.

    Source checked

Focus
Skill + Relational
Format
Individual
Duration
Medium-term

Condition-specific assessments

Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.

Psychosis & Schizophrenia Spectrum

Population and scope: Adults with non-affective psychosis or schizophrenia, as part of coordinated clinical care, including first episodes or recurrent acute episodes.

Guideline recommendation

NICE CG178 offers individual CBT for psychosis, including during acute illness or later (1.4.4.1). First-episode and recurrent acute care combine it with antipsychotic treatment (1.3.4.1; 1.4.2.1). Delivery is manual-based, one to one, with at least 16 planned sessions (1.3.7.1). If medication is declined, 1.3.4.2 specifies monitoring and prompt review. This assessment does not generalize to all affective or substance-induced psychoses.

Source assessment dated

Motivational Interviewing

Tradition
Humanistic
Founder
Miller / Rollnick (1983)
Review status
1 condition assessment available
Official sources
Guidelines and official sources (14)

13 clinical guideline checks · 1 professional reference check

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • Alcohol-use disorders: diagnosis, assessment and management (CG115)

    NICE · 2011 · Clinical guideline · 1.3.1.1

    Recommendation for the stated population

    NICE recommends an initial motivational intervention incorporating key MI elements. CG115 is alcohol-specific, not a blanket all-substances endorsement.

    Scope: People who misuse alcohol, at initial assessment

    Source checked

  • Enhancing motivation for change in substance use disorder treatment (TIP 35)

    SAMHSA · Updated 2019; PEP19-02-01-003 · Professional reference · Executive summary; Chapter 3

    Discussed in the source

    TIP35 gives clinical implementation guidance for motivational interviewing. Label it as a SAMHSA treatment manual, not a graded CPG recommendation.

    Scope: Substance-use-disorder treatment

    Source checked

  • Clinical Practice Guideline for Diagnosis and Treatment of Hypertension in Primary Care

    VA/DoD · August 2026 · Clinical guideline · Sidebar 5, p.22

    Discussed in the source

    VA/DoD names motivational interviewing as a way to deliver lifestyle support. This implementation sidebar does not assign MI a separate evidence grade.

    Scope: Lifestyle support alongside home blood-pressure monitoring for hypertension.

    Source checked

  • Management of First-Episode Psychosis and Schizophrenia

    VA/DoD · 2023; full PDF labelled Version 2.0, April 2023 · Clinical guideline · Recommendation 27; pp.37,82–83

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against motivational interviewing for medication adherence in schizophrenia. This conclusion concerns the stated outcome and population.

    Scope: Adults with schizophrenia; improving medication adherence.

    Source checked

  • Clinical Practice Guideline for the Management of Substance Use Disorders

    VA/DoD · August 2021; version 5.0 · Clinical guideline · Appendix C, section F, p.117; recommendations 15 and 23

    Discussed in the source

    The guideline distinguishes MI from MET, which adds systematic assessment and personalized feedback. Its named MET recommendations should not be read as separate recommendations for every use of MI.

    Scope: MI principles within structured motivational enhancement therapy for substance-use disorders.

    Source checked

  • Clinical Practice Guideline for Tobacco Use Treatment

    VA/DoD · January 2026; version 3.0 · Clinical guideline · Recommendation 1; pp.35, 39–40; Appendix I, p.129

    Recommendation for the stated population

    VA/DoD weakly recommends MI to increase treatment engagement. This recommendation concerns entering treatment, rather than the abstinence effect of MI used alone.

    Scope: Adults who use tobacco or nicotine; engagement in cessation treatment.

    Source checked

  • Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea

    US Department of Veterans Affairs / Department of Defense · Version 3.0; January 2025; evidence through 2024-03-31; current PDF filename dated 2025-09-15 · Clinical guideline · Recommendation 7 discussion, p.50

    Discussed in the source

    The discussion advises a patient-centered motivational interviewing approach to encourage engagement in insomnia treatment. It does not grade MI as a standalone insomnia treatment.

    Scope: Encouraging adults reluctant to engage in CBT-I or brief behavioral treatment for insomnia.

    Source checked

  • Management of Adult Overweight and Obesity

    US Department of Veterans Affairs / Department of Defense · Version 4.0; September 2025; evidence through January 2025 · Clinical guideline · Sidebar 1; Appendix O.C.b, pp.173–174

    Discussed in the source

    The guideline describes MI techniques for engagement, while noting limited evidence for follow-through with weight-management treatment. This practice guidance is not a separately graded MI recommendation.

    Scope: Engagement with recommended weight-management treatment in adults with overweight or obesity.

    Source checked

  • Use of Opioids in the Management of Chronic Pain

    US Department of Veterans Affairs / Department of Defense · Version 4.0; May 2022; evidence through April 2021 · Clinical guideline · Algorithm Sidebar B, p.28; Recommendations 12–13 discussion, pp.52–54

    Discussed in the source

    MI appears among non-opioid care options and in tapering studies. The guideline weakly supports collaborative tapering but is neutral on specific tapering strategies; it does not separately grade MI.

    Scope: Chronic pain care and collaborative opioid tapering.

    Source checked

  • Clinical Practice Guideline for Management of Stroke Rehabilitation

    VA/DoD · May 2024; version 5.0 · Clinical guideline · Recommendation 38; pp.30, 90–91

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against solution-focused psychological interventions, explicitly including MI. This neutral finding concerns prevention, not treatment of established depression.

    Scope: Preventing the onset of depression following stroke.

    Source checked

  • Clinical Practice Guideline for Psychological and Other Nonpharmacological Treatment of Chronic Musculoskeletal Pain in Adults

    American Psychological Association · Approved August 6, 2024 · Clinical guideline · Other treatments reviewed, printed p.10

    Discussed in the source

    APA reports insufficient evidence for this comparison. The table groups these approaches without assigning separate protocol grades.

    Scope: Knee osteoarthritis; the reviewed CBT/motivational-interviewing/pain-coping-skills category versus usual care.

    Source checked

  • Clinical Practice Guideline for Multicomponent Behavioral Treatment of Obesity and Overweight in Children and Adolescents: Current State of the Evidence and Research Needs

    American Psychological Association · Approved March 2018; update in progress · Clinical guideline · Summary of recommendations, printed p.8; Table 1, p.9

    Insufficient evidence for or against

    APA finds insufficient evidence to prefer MI or other selected components over alternatives. This does not recommend MI alone or address eating-disorder treatment.

    Scope: Ages 2–18 with overweight or obesity; MI as one component of a family behavioral program.

    Source checked

  • Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

    World Health Organization · Third edition, 20 November 2023 · Clinical guideline · DRU3 justification and remarks, p. 70 (PDF p. 102)

    Discussed in the source

    WHO discusses motivational interviewing findings, but the recommendation names CBT and contingency management. Inclusion in the review is not a separate recommendation for MI.

    Scope: Adults with cocaine or stimulant dependence.

    Source checked

  • Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

    World Health Organization · Third edition, 20 November 2023 · Clinical guideline · ALC2, pp. 13–14 (PDF pp. 45–46)

    Discussed in the source

    Motivational interviewing is discussed within the reviewed psychosocial interventions. WHO conditionally recommends structured psychosocial treatment as a group, with low-certainty evidence, while noting uncertainty about individual therapy types versus usual care.

    Scope: Adults with alcohol dependence.

    Source checked

Focus
Relational + Behavioral
Format
Individual
Duration
Short-term

Condition-specific assessments

Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.

Eating Disorders

Population and scope: Community-recruited women with binge-eating disorder receiving an adapted MI session plus self-help; separately, patients awaiting intensive eating-disorder treatment.

Randomized studies

Randomized research supports specific adjunctive uses: Cassin 2008 tested one adapted MI session added to a handbook against handbook alone, with better 16-week binge-eating outcomes. A separate small pretreatment trial studied treatment completion. These findings do not establish stand-alone MI for all eating disorders.

Source assessment dated

How they work

CBTp

Core mechanism: Normalizing psychotic experiences + examining evidence for beliefs + reducing distress associated with symptoms

Ontology: Psychotic symptoms exist on a continuum; distress is driven by appraisal of experiences, not just their presence

Motivational Interviewing

Core mechanism: Resolving ambivalence through evocation of client's own change talk; autonomy support increases intrinsic motivation

Ontology: Ambivalence about change is normal; confrontation increases resistance, empathy reduces it

Related condition topics

These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.

0 shared · 1 CBTp-only · 3 Motivational Interviewing-only

Linked only in the CBTp entry

What each assumes — and misses

CBTp

Philosophical roots: Jaspers (form vs. content of psychotic experience); continuum models of psychosis; social constructionism (what counts as delusional is partly social); anti-psychiatry echoes (Laing, Szasz)

Blind spots: Effect sizes debated when controlling for researcher allegiance; may underemphasize social determinants of psychosis

Therapeutic voice: You mentioned the voices got louder this week. What was happening in your life right before they intensified?

Motivational Interviewing

Philosophical roots: Rogers (empathy, autonomy); Kierkegaard (stages, either/or); Festinger (cognitive dissonance); Deci & Ryan (self-determination theory)

Blind spots: Not a standalone treatment for most conditions; because the method is strategic, its autonomy language can be used instrumentally, steering a client toward an outcome the clinician has already chosen

Therapeutic voice: So drinking is the one thing that reliably quiets your head at night, and you didn't like who you were on Sunday morning. Where does that leave you?

Choosing between them

CBTp (Cognitive-Behavioral) and Motivational Interviewing (Humanistic) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.

For deeper coverage: see the full CBTp and Motivational Interviewing pages, or use the interactive comparison tool to add more modalities to this comparison.